Small (<2-cm) upper-tract urothelial carcinoma: Evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography

Radiology

Volumn 247, Issue 2, 2008, Pages 451-457

  Takahashi, Naoki ^a   Kawashima, Akira ^a   Glockner, James F ^a   Hartman, Robert P ^a   Leibovich, Bradley C ^a   Brau, Anja C S ^b   Beatty, Philip J ^b   King, Bernard F ^a  

^a MAYO CLINIC   (United States)

^b GE HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

AGED; ARTICLE; CANCER RESEARCH; CANCER SIZE; CANCER STAGING; CARCINOMA IN SITU; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MCNEMAR TEST; MEDICAL RECORD; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RENOGRAPHY; RETROSPECTIVE STUDY; URETER CARCINOMA; UROGRAPHY; ANALYSIS OF VARIANCE; BLADDER TUMOR; METHODOLOGY; NONPARAMETRIC TEST; PATHOLOGY; THREE DIMENSIONAL IMAGING;

AGED; ANALYSIS OF VARIANCE; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; URINARY BLADDER NEOPLASMS;

EID: 44449114685     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2472070798     Document Type: Article

References (23)

1. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998;52:594-601.
2. Kirkali Z, Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 2003;47:155-169.
3. Caoili EM, Cohan RH, Inampudi P, et al. MDCT urography of upper tract urothelial neoplasms. AJR Am J Roentgenol 2005;184:1873-1881.
4. Fritz GA, Schoellnast H, Deutschmann HA, Quehenberger F, Tillich M. Multiphasic multidetector-row CT (MDCT) in detection and staging of transitional cell carcinomas of the upper urinary tract. Eur Radiol 2006;16:1244-1252.
5. Elliott DS, Segura JW, Lightner D, Patterson DE, Blute ML. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology 2001;58:174-178.
6. Soderdahl DW, Fabrizio MD, Rahman NU, Jarrett TW, Bagley DH. Endoscopic treatment of upper tract transitional cell carcinoma. Urol Oncol 2005;23:114-122.
7. Elliott DS, Blute ML, Patterson DE, Bergstralh EJ, Segura JW. Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology 1996;47:819-825.
8. Aerts P, Van Hoe L, Bosmans H, Oyen R, Marchal G, Baert AL. Breath-hold MR urography using the HASTE technique. AJR Am J Roentgenol 1996;166:543-545.
9. Regan F, Bohlman ME, Khazan R, Rodriguez R, Schultze-Haakh H. MR urography using HASTE imaging in the assessment of ureteric obstruction. AJR Am J Roentgenol 1996;167:1115-1120.
10. Tang Y, Yamashita Y, Namimoto T, et al. The value of MR urography that uses HASTE sequences to reveal urinary tract disorders. AJR Am J Roentgenol 1996;167:1497-1502.
11. Sudah M, Vanninen R, Partanen K, Heino A, Vainio P, Ala-Opas M. MR urography in evaluation of acute flank pain: T2-weighted sequences and gadolinium-enhanced three-dimensional FLASH compared with urography - fast low-angle shot. AJR Am J Roentgenol 2001;176:105-112.
12. Chahal R, Taylor K, Eardley I, Lloyd SN, Spencer JA. Patients at high risk for upper tract urothelial cancer: evaluation of hydronephrosis using high resolution magnetic resonance urography. J Urol 2005;174:478-482.
13. Nolte-Ernsting CC, Bucker A, Adam GB, et al. Gadolinium-enhanced excretory MR urography after low-dose diuretic injection: comparison with conventional excretory urography. Radiology 1998;209:147-157.
14. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999;212:876-884.
15. Jung P, Brauers A, Nolte-Ernsting CA, Jakse G, Gunther RW. Magnetic resonance urography enhanced by gadolinium and diuretics: a comparison with conventional urography in diagnosing the cause of ureteric obstruction. BJU Int 2000;86:960-965.
16. Shokeir AA, El-Diasty T, Eassa W, et al. Diagnosis of noncalcareous hydronephrosis: role of magnetic resonance urography and noncontrast computed tomography. Urology 2004;63:225-229.
17. Obuchi M, Ishigami K, Takahashi K, et al. Gadolinium-enhanced fat-suppressed T1-weighted imaging for staging ureteral carcinoma: correlation with histopathology. AJR Am J Roentgenol 2007;188:W256-W261.
18. Obuchi M, Takahara T, Takahashi M, et al. Breath-hold 3D MR urography with 2 mL Gd-DTPA injection [in Japanese]. Nippon Igaku Hoshasen Gakkai Zasshi 1998;58:163-165.
19. Szopinski K, Szopinska M, Borowka A, Jakubowski W. Magnetic resonance urography: initial experience of a low-dose Gd-DTPA-enhanced technique. Eur Radiol 2000;10:1158-1164.
20. Hughes J, Jan W, Goodie J, Lund R, Rankin S. MR urography: evaluation of different techniques in non-dilated tracts. Clin Radiol 2002;57:989-994.
21. Farres MT, Gattegno B, Ronco P, Flahault A, Paula-Souza R, Bigot JM. Nonnephrotoxic, dynamic, contrast enhanced magnetic resonance urography: use in nephrology and urology. J Urol 2000;163:1191-1196.
22. Ergen FB, Hussain HK, Carlos RC, et al. 3D excretory MR urography: improved image quality with intravenous saline and diuretic administration. J Magn Reson Imaging 2007;25:783-789.
23. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007;242:647-649.